ArticleClinical rheumatology2021

Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy.

Yongpeng Ge et al.PubMed ↗Publisher ↗

No numbers read from the abstract.